Restrained chondrocyte proliferation and maturation with abnormal growth plate vascularization and ossification in human FGFR-3(G380R) transgenic mice

Human Molecular Genetics

Volumn 9, Issue 2, 2000, Pages 249-258

  Segev, Orit ^a,b   Chumakov, Irina ^a,b   Nevo, Zvi ^c   Givol, David ^a   Madar Shapiro, Liora ^b   Sheinin, Yuri ^b   Weinreb, Miron ^c   Yayon, Avner ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b ProChon Biotech Ltd   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR;

ACHONDROPLASIA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE DEVELOPMENT; CARTILAGE CELL; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; ENCHONDRAL OSSIFICATION; GROWTH PLATE; HETEROZYGOTE; HOMOZYGOSITY; HYPOPLASIA; LONG BONE; MACROCEPHALY; MOUSE; MUTATION; NONHUMAN; OSSIFICATION; POINT MUTATION; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; TRANSGENE; TRANSGENIC MOUSE; VASCULARIZATION;

ANIMALIA; MUS MUSCULUS;

EID: 0033970893     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.2.249     Document Type: Article

References (52)

1. Andersen, P.E.J. and Hauge, M. (1989) Congenital generalised bone dysplasia: a clinical, radiological, and epidemiological survey. J. Med. Genet., 26, 37-44.
2. Iannotti, J.P., Goldstein, S., Kuhn, J., Lipiollo, L. and Kaplan, F.S. (1994) Growth plate and bone development. In Simon, S.R. (ed.), Orthopaedic Basic Science. American Academy of Orthopaedic Surgeons, Rosemont, IL, pp. 185-217.
3. Rousseau, F., Bonaventure, J., Legeai-Mallet, L., Pelet, A., Rozet, J.M., Maroteaux, P., Le Merrer, M. and Munnich, A. (1994) Mutations in the gene encoding Fgfr3 in achondroplasia. Nature, 371, 252-254.
4. Prinos, P., Kilpatrick, N.W. and Tsipouros, P. (1995) A common FGFR3 gene mutation in hypochondroplasia. Hum. Mol. Genet., 4, 2097-2101.
5. Horton, W.A., Hood, O.J., Mashado, M.A. and Campbell, D. (1988) Growth plate cartilage studies in achondroplasia. In Nicoletti, B., Ascani, E., McKusick, V.A. and Kopits, S.E. (eds), Human Achondroplasia: A Multidisciplinary Approach. Plenum, pp. 81-89.
6. Rimoin, D.L., Hughes, G.N., Kaufman, R.L., Rosenthal, R.E., McAlister, W.H. and Silberberg, R. (1970) Endochondral ossification in achondroplastic dwarfism. N. Engl. J. Med., 183, 728-735.
7. Shiang, R., Thompson, L.M., Zhu, Y.-Z., Church, D.M., Winokur, S.T. and Wasmuth, J.J. (1994) Mutations in transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell, 78, 335-342.
8. Basilico, C. and Moscatelli, D. (1992) The FGF family of growth factors and oncogenes. Adv. Cancer Res., 59, 115-165.
9. Givol, D. and Yayon, A. (1992) Complexity of FGF receptors: genetic basis for structural diversity and functional specificity. FASEB J., 6, 3362-3369.
10. Sahni, M., Ambrosetti, D.C., Mansukhani, A., Gertner, R., Levi, D. and Basilico, C. (1999) FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-I pathway. Genes Dev., 13, 1361-1366.
11. De Luca, F. and Baron, J. (1999) Control of bone growth by fibroblast growth factors. Trends Endocrinol. Metab., 10, 61-65.
12. Webster, M.K. and Donoghue, D.J. (1996) constitutive activation of FGFR3 by the transmembrane domain point mutation found in achondroplasia. EMBO J., 15, 520-527.
13. Naski, M.C., Wang, Q., Xu, J. and Ornitz, D.M. (1996) Graded activation of FGFR3 by mutations causing achondroplasia and thanatophoric dysplasia. Nature Genet., 13, 233-237.
14. Bellus, G.A., Hefferon, T.W., Ortiz, R.I., Hecht, J.T., Horton, W.A., Mashado, M., Kaitila, I., McIntosh, I. and Francomano, C.A. (1995) Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am. J. Hum. Genet., 56, 368-373.
15. Superti-Furga, A., Eich, G., Bucher, H.U., Wisser, J., Giedion, A., Gitzelmann, R. and Steinmann, B. (1995) A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in newborns with achondroplasia. Eur. J. Pediatr., 154, 215-219.
16. Ikegawa, S., Fukushima, Y., Isomura, M., Takada, F. and Nakamura, Y. (1995) Mutations of the FGFR3 gene in one familial and six sporadic cases of achondroplasia in Japanese patients. Hum Genet., 96, 309-311.
17. McKusick, V.A., Kelly, T.E. and Dorst, J.P. (1973) Observations suggesting allelism of the achondroplasia and hypochondroplasia genes. J. Med. Genet., 10, 11-16.
18. Horton, W.A. and Hecht, J.T. (1993) The chondrodysplasias. In Royce, P.M. and Steinmann, B. (eds), Connective Tissue and its Heritable Disorders: Molecular, Genetic and Medical Aspects. John Wiley & Sons, pp. 641-675.
19. Stanescu, R., Stanescu, V. and Moroteaux, P. (1990) Homozygous achondroplasia: morphologic and biochemical study of cartilage. Am. J. Med. Genet., 27, 412-421.
20. Bonaventure, J., Rousseau, F., Legeai-Mallet, L., Merrer, M.L., Munnich, A. and Maroteaux, P. (1996) Common mutations in the fibroblast growth factor receptor 3 gene account for achondroplasia, hypochondroplasia and thanatophoric dwarfism. Am. J. Med. Genet., 63, 148-154.
21. Lewanda, A.F., Meyers, G.A. and Jabs, E.W. (1996) Craniosynostosis and skeletal dysplasias: fibroblast growth factor receptor defects. Proc. Assoc. Am. Phys., 108, 19-24.
22. Wuechner, C., Sandberg Nordqvist, A.-C., Winterpacht, A., Zabel, B. and Schalling, M. (1996) Developmental expression of splicing variants of fibroblast growth factor receptor 3 (FGFR3) in mouse. Int. J. Dev. Biol., 40, 1185-1188.
23. Peters, K., Ornitz, D., Werner, S. and Williams, L. (1993) Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev. Biol., 155, 423-430.
24. McEwen, D.G. and Ornitz, D.M. (1998) Regulation of the fibroblast growth factor receptor 3 promoter and intron I by SpI family transcription factors. J. Biol. Chem., 273, 5349-5357.
25. Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A. and Leder, P. (1996) Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell, 84, 911-921.
26. Colvin, J.S., Bohne, B.A., Harding, G.W., McEwen, D.G. and Ornitz, D.M. (1996) Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nature Genet., 12, 390-397.
27. Langer, L.O.J., Baumann, P.A. and Gorlin, R.J. (1967) Achondroplasia. Am. J. Roentgenol., 100, 12-26.
28. Gorlin, R.J. (1997) Fibroblast growth factors, their receptors and receptor disorders. J. Cranio-Maxillofacial Surg., 25, 69-79.
29. Sharrard, W.J.W. (1973) Cartilaginous dysplasias with abnormal maturation of growth plate chondroblasts. In Paediatric Orthopaedics and Fractures. Blackwell Science, pp. 59-63.
30. Briner, J., Giedion, A. and Spycher, M.A. (1991) Variation of quantitative and qualitative changes of enchondral ossification in heterozygous achondroplasia. Orthoped. Res. Pract., 187, 271-278.
31. Horton, W.A., Hood, O.J., Mashado, M.A., Ahmed, S. and Griffey, E.S. (1988) Abnormal ossification in T.D. Bone, 9, 53-61.
32. Nilsson, A., Ohlsson, C., Isaksson, O.G., Lindahl, A. and Isgaard, J. (1994) Hormonal regulation of longitudinal bone growth. Eur. J. Clin. Nutr., 48, S158-S160.
33. Mason, I.J. (1994) The ins and outs of FGFs. Cell, 78, 547-552.
34. Wang, Y., Spatz, M.K., Kannan, K., Hayk, H., Avivi, A., Gorivodsky, M., Pines, M., Yayon, A., Lonai, P. and Givol, D. (1999) A mouse model for achondroplasia produced by targeting FGFR-3. Proc. Natl Acad. Sci. USA, 96, 4455-4460.
35. Naski, M.C., Colvin, J.S., Coffin, J.D. and Ornitz, D.M. (1998) Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development. 125, 4977-4988.
36. Weil, D., Power, M.A., Webb, G.C. and Li, C.L. (1997) Antisense transcription of a murine FGFR-3 pseudogene during fetal development. Gene, 187, 115-122.
37. Tokunaga, H., Watanabe, J., Kanai, K., Sakaida, M. and Kanamura, S. (1987) Glucose 6-phosphatase and glycogen phosphorylase activities in chondrocytes in epiphyseal cartilage of growing rats. Anat. Rec., 219, 356-362.
38. Segre, G.V. (1996) Receptors for PTH and PTHrP. In Bilezikian, J.P., Raisz, L.G. and Rodan, G.A. (eds), Principles of Bone Biology. pp. 393-395.
39. Webster, M.K. and Donoghue, D.J. (1997) FGFR activation in skeletal disorders: too much of a good thing. Trends Genet., 13, 178-182.
40. Monsonego-Ornan, E., Adar, R., Feferman, T., Segev, O. and Yayon, A. (2000) The achondroplasia mutation G380R in Fgfr3 uncouples receptor activation from down-regulation. Mol. Cell. Biol., in press.
41. Delezoide, A.-L., Benoist, C.L., Legeai-Mallet, L., Brice, P., Senee, V., Yayon, A., Munnich, A., Vekemans, M. and Bonaventure, J. (1997) Abnormal FGFR3 expression in cartilage of thanatophoric dysplasia fetuses. Hum. Mol. Genet., 6, 1899-1906.
42. Vu, T.H., Shipley, J.M., Bergers, G., Berger, J.E., Helms, J.A., Hanahan, D., Shapiro, S.D., Senior, R.M. and Werb, Z. (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell, 93, 411-422.
43. Folkman, J. and Klagsburn, M. (1987) Angiogenic factors. Science, 235, 442-447.
44. Ferrara, N., Houck, K.A., Jakeman, L.B., Winer, J. and Leung, D.W. (1991) The vascular endothelial growth factor family of polypeptides. J. Cell. Biochem., 47, 211-218.
45. Rapraeger, A.C., Krufka, A. and Olwin, B.B. (1991) Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science, 252, 1705-1707.
46. Aviezer, D., Hecht, D., Safran, M., Eisinger, M., David, G. and Yayon, A. (1994) Perlecan, basal lamina proteoglycan promotes bFGF-receptor binding, mitogenesis and angiogenesis. Cell, 79, 1005-1013.
47. Moses, M.A. and Langer, R. (1991) A metalloproteinase inhibitor as an inhibitor of neovascularization. J. Cell. Biochem., 47, 230-235.
48. Keegan, K., Johnson, D., Williams, L. and Hayman, M. (1991) Isolation of an additional member of the fibroblast growth factor receptor family, FGFR 3. Proc. Natl Acad. Sci. USA, 88, 1095-1099.
49. Inouye, M. (1976) Differential staining of cartilage and bone in fetal mouse skeleton by alcian blue and alizarin red S. Congen. Anom., 16, 171-173.
50. Weinreb, M., Suponitzky, I. and Keila, S. (1997) Systemic administration of an anabolic dose of PGE2 in young rats increases the osteogenic capacity of bone marrow. Bone, 20, 521-526.
51. McLeod, M.J. (1980) Differential staining of cartilage and bone in whole mouse fetuses by alcian blue and alizarin red S. Teratology, 22, 299-301.
52. Morgan, D.F. and Young, R.F. (1980) Spinal neurological complications of achondroplasia. J. Neurosurg., 52, 463-472.